We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
AMAG is in the midst of launching controversial female libido drug Vyleesi after its approval in June. While the drugmaker has high hopes for the drug, analysts have posted less-than-stellar forecasts.